Kids & teens (for parents) · New York
Studies for children and teens in New York
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
97 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Brooklyn, NY + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- New York, NY + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- The Bronx, NY + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency
Jaguar Gene Therapy, LLC
- Location
- New York, NY + 2 other US sites
- Eligibility basics
- Ages 2–9
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- New York, NY + 11 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- New York, NY + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Pfizer
- Location
- New York, NY + 6 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Alkermes, Inc.
- Location
- New York, NY + 14 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Buffalo, NY + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 4
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Bausch Health Americas, Inc.
- Location
- Stony Brook, NY + 13 other US sites
- Eligibility basics
- Ages 9–11
- RecruitingPhase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Celgene
- Location
- New York, NY
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Pfizer
- Location
- New York, NY + 2 other US sites
- Eligibility basics
- Ages 10 mo–17
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Albany, NY + 6 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Buffalo, NY + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- New York, NY + 6 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- New Hyde Park, NY + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Takeda
- Location
- New Hyde Park, NY + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
AMAG Pharmaceuticals, Inc.
- Location
- The Bronx, NY + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- The Bronx, NY + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Woodbury, NY + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 4
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Bausch Health Americas, Inc.
- Location
- The Bronx, NY + 3 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
- Location
- Buffalo, NY + 9 other US sites
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingPhase 2
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
Omeros Corporation
- Location
- Valhalla, NY + 2 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingHealthy volunteers
NIRS Monitoring in the NICU and AKI
NYU Langone Health
- Location
- New York, NY
- Eligibility basics
- Ages 6 mo–7 mo